The Daraprim Case: How a Drug’s Price Rose by 75,000 %

Pyrimethamine2DACS.svgBy Simon Gottwalt. The recent price hike of Daraprim, a 62 year old medicine used against toxoplasmosis, created a massive public outcry against Turing Pharmaceuticals, who had just acquired the drug, and its CEO Martin Shkreli, making him “the most hated man in America”. How is it possible that the cost of a pill whose patent has long expired goes through the roof overnight? Continue reading

Posted in Drug Pricing, Drug regulation | Leave a comment

Secretary-General Appoints Two Former Presidents, 14 Others as Members of High-Level Panel on Access to Medicines

UNUnited Nations, November 19, 2015. United Nations Secretary-General Ban Ki-moon announced today the establishment of a high-level panel on health technology innovation and access.
Comprising 16 eminent, well-respected individuals with a deep knowledge and understanding of the broad range of trade, public health, human rights and legal issues associated with access to treatment, the panel’s co-chairs are Ruth Dreifuss, former President of Switzerland, and Festus Mogae, former President of Botswana. Continue reading

Posted in High Level Panel | Leave a comment

More than 15m people on life-saving HIV drugs – not enough, says MSF

HIVThe Guardian, MSF Access, November 24, 2015. UNAids says additional 2 million people began antiretrovirals in the last year, but campaigners say figure must reach 3 million a year to meet 2020 targets. Continue reading

Posted in HIV/Aids | Leave a comment

Physicians call for fairness in drug prices, availability

DollarMedAmerican Medical Association, November 17, 2015. In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs. Continue reading

Posted in Anti competition, Biologics, Transparency | Leave a comment

Speak up for affordable medicine

Many people living in South Africa struggle to pay outrageous medical bills or forgo medication when they cannot afford it, say the writers. File picture: Paballo ThekisoIol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson.  Continue reading

Posted in BRICS, Drug Pricing, Fix the patent law, South Africa's Patent Act | Leave a comment

WHO proposes to join Global Fund’s IP enforcement initiative

Third World Network, November 19, 2015. By KM Gopakumar. Geneva – The World Health Organization has proposed to join the intellectual property enforcement initiative of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Continue reading

Posted in Counterfeit, Global Fund, WHO | Leave a comment

Most WTO members seek to continue Doha round talks at Nairobi meet

ModiLivemint, November 23, 2015. Geneva – Many members of the World Trade Organization (WTO) have called for reaffirming the commitment to continue negotiations on all outstanding issues of the Doha Development Agenda (DDA) at the Nairobi Ministerial Declaration, a panel of three facilitators said on Thursday.  Continue reading

Posted in TRIPS, WTO | Leave a comment